Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stein, W. D
Right arrow Articles by Bates, S. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stein, W. D
Right arrow Articles by Bates, S. E
[Cancer Research 64, 2805-2816, April 15, 2004]
© 2004 American Association for Cancer Research


Regular Articles

A Serial Analysis of Gene Expression (SAGE) Database Analysis of Chemosensitivity

Comparing Solid Tumors with Cell Lines and Comparing Solid Tumors from Different Tissue Origins

Wilfred D Stein1,3, Thomas Litman2, Tito Fojo3 and Susan E Bates3

1 Department of Biological Chemistry, Silberman Institute of Life Sciences’ Hebrew University, Jerusalem, Israel; 2 Bioinformatics Centre, University of Copenhagen, Copenhagen, Denmark; and 3 National Cancer Institute, NIH, Bethesda, Maryland

Drug sensitivity and resistance has been most extensively studied in cell lines carried in tissue culture. Furthermore, cell lines have been widely used in testing new anticancer agents, despite the widely recognized observation that cell lines are more sensitive to cytotoxic drugs than are their corresponding solid tumors. We used the Serial Analysis of Gene Expression (SAGE) database to identify differences between solid tumors and cell lines, hoping to detect genes that could potentially explain differences in drug sensitivity. SAGE libraries were available for both solid tumors and cell lines from breast, colon, ovarian, pancreatic, and prostate carcinomas and from gliomas and medulloblastomas. Sixty-two genes were identified as overexpressed in tumors. The immune response and complement pathways were the significant common themes, with extracellular matrix (ECM) proteins third. For the 61 genes overexpressed in cell lines, protein synthesis was the dominant theme. We next used the SAGE database to identify genetic differences between tumor types that convey a broad range of survival to the patients that bear them as distant metastases. SAGE gene expression data were correlated with 5-year survivals documented in the SEER (Surveillance, Epidemiology and End-Results) database for patients diagnosed with "distant" or metastatic cancers. These are unlikely to be amenable to surgical resection; therefore, survival here reflects, to some extent, sensitivity to systemic therapy, i.e., chemotherapy. Using survival data as a surrogate of chemotherapy sensitivity, a spectrum can be generated, with testicular cancer at one end and pancreatic cancer at the other. Favorable 5-year survival, despite a distant presentation, correlates with expression of protein synthesis genes. Poor 5-year survival correlates with expression of cell adhesion, cytoskeletal, and ECM genes, a pattern similar to that found to distinguish solid tumors from the more cytotoxin-sensitive cancer cell lines. One interpretation is that resistance to chemotherapy may arise, in part, from the adherent, relatively inert condition (i.e., low in protein synthesis potential) of refractory cancers. Thus, attachment or ECM genes could be targets for anticancer therapy.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
L. Guo, Y. Ma, R. Ward, V. Castranova, X. Shi, and Y. Qian
Constructing Molecular Classifiers for the Accurate Prognosis of Lung Adenocarcinoma.
Clin. Cancer Res., June 1, 2006; 12(11): 3344 - 3354.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. R. Estrada, M. Salanga, D. R. Bielenberg, W. B. Harrell, D. Zurakowski, X. Zhu, M. R. Palmer, M. R. Freeman, and R. M. Adam
Behavioral Profiling of Human Transitional Cell Carcinoma Ex vivo.
Cancer Res., March 15, 2006; 66(6): 3078 - 3086.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Terry, J. M. Lubieniecka, W. Kwan, S. Liu, and T. O. Nielsen
Hsp90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin Prevents Synovial Sarcoma Proliferation via Apoptosis in In vitro Models
Clin. Cancer Res., August 1, 2005; 11(15): 5631 - 5638.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. G. Peters, D. M. Kudla, J. A. DeLoia, T. J. Chu, L. Fairfull, R. P. Edwards, and R. E. Ferrell
Comparative Gene Expression Analysis of Ovarian Carcinoma and Normal Ovarian Epithelium by Serial Analysis of Gene Expression
Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1717 - 1723.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Sandberg and I. Ernberg
Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI)
PNAS, February 8, 2005; 102(6): 2052 - 2057.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
G. Szakacs and M. M. Gottesman
Comparing Solid Tumors with Cell Lines: Implications for Identifying Drug Resistance Genes in Cancer
Mol. Interv., December 1, 2004; 4(6): 323 - 325.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.